Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

09:45 ET The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players

The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players Download the full report:...


09:43 ET Elekta Unity, primer acelerador lineal MR de alto campo a nivel mundial, recibe la Marca CE

El nuevo sistema de radioterapia se implementará de forma clínica en Europa, marcando el comienzo de la transformación en la precisión y...


09:41 ET Elekta Unity, o primeiro acelerador linear de ressonância magnética de alto campo do mundo, recebe a marca CE

O novo sistema de radioterapia será implementado clinicamente na Europa, representando uma transformação no tratamento oncológico personalizado e...


09:37 ET Elekta Unity, weltweit erster Hochfeld-MR-Linearbeschleuniger, erhält CE-Kennzeichen

Neues Strahlentherapiesystem wird in Europa nun klinisch umgesetzt werden und läutet dabei eine Transformation bei Präzision und...


09:32 ET Elekta Unity, 's werelds eerste high-field MR-versneller, ontvangt CE-keurmerk

Het nieuwe radiotherapiesysteem wordt nu klinisch in gebruik genomen in Europa, waarmee een nieuw tijdperk in precisie en gepersonaliseerde...


09:30 ET Elekta Unity, världens första 1,5T-baserade MR-strålkanon, får CE-märkning

Det nya strålterapisystemet kan nu användas kliniskt i Sverige och Europa och möjliggör en ny nivå av skräddarsydda cancerbehandlingar med...


09:24 ET Elekta Unity, le premier IRM accélérateur haut champ au monde, obtient le marquage CE

Un nouveau système de radiothérapie va désormais pouvoir être utilisé en routine clinique en Europe révolutionnant ainsi la précision et le...


09:20 ET Elekta Unity, World's First High-Field MR-Linac, Receives CE Mark

New radiation therapy system will now be implemented clinically in Europe, ushering in a transformation in precision and personalized...


09:00 ET Growing Demand for Biotechnologies are Expected to Grow

Data published by Grand View Research, Inc., indicates that the global biotechnology market size is expected to reach USD 604.40 Billion by 2020....


09:00 ET Arcuro Medical Receives FDA Regulatory Clearance

Arcuro Medical Ltd. ("Arcuro"), a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced today that it...


09:00 ET La sociedad estratégica entre Chronicled y OCEASOFT ofrecerá una solución Bluetooth de control de la temperatura con cadena de bloques integrada para la industria de las ciencias de la vida

Chronicled, Inc., una compañía de soluciones inteligentes para la cadena de abastecimiento con sede en San Francisco, California, y...


09:00 ET Migraine Abortion Phase 3 Trial (TEAM study) with Cefaly® ACUTE Medical Device is Progressing Quickly

The Cefaly® ACUTE medical device, recently cleared by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine, is the...


09:00 ET Chronicled and OCEASOFT Strategic Partnership to Deliver Blockchain-Integrated Bluetooth Temperature Monitoring Solution in Life Science Industry

Chronicled, Inc. a smart supply chain solutions company based in San Francisco, CA, and OCEASOFT, a data logging company based in Montpellier,...


08:45 ET Xyntek Announces Technology Open House on June 21

Xyntek, Inc., a Global Leader in IT, Automation, & Compliance solutions will be holding their Technology Open House on Thursday, June 21st at...


08:40 ET Concordia International Corp. Announces Amendments to its CBCA Plan of Arrangement in Connection with its Recapitalization Transaction

OAKVILLE, ON, June 18, 2018 /PRNewswire/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR) announced today that, in...


08:00 ET DreaMed Diabetes Granted FDA Authorization to Market Advisor Pro, Offering Personalized Optimization of Insulin Pump Therapy

DreaMed Diabetes, developer of personalized diabetes management solutions, announced today that the U.S Food and Drug Administration (FDA) has...


07:18 ET EFIC: Fresh Ideas in Pain Research

- Creative approaches to research by young scientists provide opportunity for new and challenging thinking to benefit patients who suffer...


07:00 ET Ionis Pharmaceuticals Appoints Damien McDevitt as Chief Business Officer

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Damien McDevitt, Ph.D. has joined the company as chief business officer. In his...


07:00 ET Protagonist Announces Phase 1 and Pre-clinical Data on Hepcidin Mimetic PTG-300 Presented at European Hematology Association Annual Meeting

Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced that results of a Phase 1 study in healthy volunteers and supportive pre-clinical...


06:51 ET SOPHiA GENETICS acquiert Interactive Biosoftware pour stimuler la croissance et accélérer l'adoption de la médecine basée sur les données dans le monde entier

SOPHiA GENETICS, le leader mondial de la médecine basée sur les données (Data-Driven Medicine), a annoncé aujourd'hui à la Conférence européenne...


06:30 ET Mallinckrodt Reports Interim Findings Of H.P. Acthar® Gel (Repository Corticotropin Injection) Studies

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, recently reported preliminary interim data from ongoing H.P....


06:30 ET In-vitro Diagnostics Market to Reach US$89,862.2 mn by 2025, Says TMR

A recent report on the market for in-vitro diagnostic tests finds that it will rise at a 5.6% CAGR over the course of the forecast period...


06:30 ET Galmed Pharmaceuticals Ltd. Announces Proposed Public Offering of Ordinary Shares

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of...


06:00 ET Data Provide Further Insight Into the Consistent Efficacy Benefits of Mavenclad in Relapsing MS

Not intended for U.S or U.K based media - Post-hoc analysis of CLARITY study suggests consistent clinical and Magnetic Resonance...


06:00 ET PharmaBoardroom Releases 'Disruptive Trends in Pharma Regulation' June 2018 Special Report

PharmaBoardroom today releases its new 36-page special report, Disruptive Trends in Pharma Regulation. While drug developers, healthcare...